Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04666012 Org: User:
Start: 12/29/20 End: 03/27/23 Due: 03/27/24

Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT05576623 Org: User:
Start: 09/14/22 End: 02/28/24 Due: 02/28/25

Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care

Phase: N/A Priority: Normal
NCT ID: NCT03425773 Org: User:
Start: 02/26/18 End: 05/13/19 Due: 05/13/20

A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects with HPV Positive HNSCC.

Phase: N/A Priority: Normal
NCT ID: NCT06797986 Org: User:
Start: 03/31/25 End: 03/31/27 Due: 03/31/28

Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05993325 Org: User:
Start: 11/27/23 End: 11/30/25 Due: 11/30/26

Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05047692 Org: User:
Start: 09/09/21 End: 06/21/23 Due: 06/21/24

Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02866006 Org: User:
Start: 10/31/16 End: 06/30/22 Due: 06/30/23

Safety and Immunogenicity of COVID-19 Vaccine, AdCLD-CoV19-1

Phase: N/A Priority: Normal
NCT ID: NCT05520970 Org: User:
Start: 08/19/22 End: 11/08/22 Due: 11/08/23